JUVENILE RHEUMATOID ARTHRITIS IN CHILDREN. MODERN DIAGNOSTICS AND TREATMENT METHODS
Vol. 5 No. 9 (2025): Eurasian Journal of Medical and Natural Sciences 51-55
Abstract
The article examines modern approaches to the diagnosis and treatment of juvenile idiopathic arthritis in children, including classification, methods for determining disease activity, standardized assessment scales, and modern pharmacological and non-drug-specific treatment methods. Special attention was paid to the importance of early and aggressive treatment, as well as the role of biological drugs. A comparative table of treatment methods is presented, showing the advantages, disadvantages, and indications for use.
Keywords:
References
Beukelman, T., Patkar, N. M., Saag, K. G., Tolleson‐Rinehart, S., Cron, R. Q., DeWitt, E. M., ... & Ruperto, N. (2011). 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis care & research, 63(4), 465-482.
Hashkes, P. J., Uziel, Y., & Laxer, R. M. (2010). The safety profile of biologic therapies for juvenile idiopathic arthritis. Nature Reviews Rheumatology, 6(10), 561-571.
Lovell, D. J., Giannini, E. H., Reiff, A., Cawkwell, G. D., Silverman, E. D., Nocton, J. J., ... & Finck, B. K. (2000). Etanercept in children with polyarticular juvenile rheumatoid arthritis. New England Journal of Medicine, 342(11), 763-769.
Petty, R. E., Southwood, T. R., Manners, P., Baum, J., Glass, D. N., Goldenberg, J., ... & International League of Associations for Rheumatology. (2004). International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. The Journal of rheumatology, 31(2), 390-392.
Ravelli, A., & Martini, A. (2007). Juvenile idiopathic arthritis. The Lancet, 369(9563), 767-778.
Readership
Downloads
Published
Issue
Section
How to Cite
